Skip to content

ICCC - IMMUCELL CORP /DE/ - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

ImmuCell Corporation

ICCC · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

ICCCImmuCell Corporation

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $12.10
52-wk low: $4.52
Prev close: $8.66
Mkt cap: $92.0M
P/E: 144.7x
Beta: 0.57

Smart money

5 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

5 holders

Combined position$2.4M

JS
Jim Simons
Q2 2026 13F
$1.7M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

Richly priced and running thin margins.

Net margin: 2.6%
P/E: 144.71
Market cap: $92M

Valuation

P/S3.00
P/B2.82

Quality

Operating margin26.9%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ICCC
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $92.00M
Beta: 0.57

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

3.0x

P/B

2.8x

Profit margin

+2.6%

Op margin

+26.9%

ROE

+2.6%

$407K

position

BR

BlackRock

Q2 2026 13F

$230K

position

2 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 2 holders

Coverage gaps for ICCC

No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

ROE

2.6%

ROA6.3%

Growth

Beta0.57